Presentation of Xeomin in Ukraine: what experts expect

On March 22, 2017, for the first time on the Ukrainian market, a unique drug Xeomin was presented. This new generation botulinum toxin has been used by leading world experts in their practice for more than 10 years, and now Ukrainian doctors also have the opportunity to evaluate its benefits. What do Ukrainian experts expect from the appearance of Xeomin in Ukraine – in an exclusive interview for estet-portal.com, said the candidate of medical sciences, dermatovenereologist of the highest category, cosmetologist, chief physician of the Madeleine Cosmetology Center, scientific director of the cosmetology department of the Ukrainian Academy of Dermatovenereology Zolotareva Valentina Grigorievna.

Valentina Grigoryevna, why do you think botulinum toxin injections have been one of the most popular aesthetic procedures for a long time?

A unique indication in cosmetology for botulinum therapy is local muscle hypertonicity of mimic muscles and platysma bands. Almost every woman has this aesthetic flaw, and there is a great desire to change her appearance, thanks to botulinum toxin therapy.

Botulinum toxin injections are truly at the forefront of cosmetics, and there is practically no woman who has never used them.

It seems to me that both we, cosmetologists and patients, believe that botulinum therapy, after all, is a panacea for the 21st century. I think so.

In your opinion, how significant is the appearance of Xeomin on the Ukrainian market?

I consider this a very significant event, because not just another botulinum toxin entered the Ukrainian market, but botulinum toxin, which has huge advantages over drugs already existing on our market. And it is thanks to these advantages that we have the opportunity to get new results. We have a safer field of operation. The doctor has a choice, and it's very cool when a doctor has the opportunity to choose. I believe that our patients only benefit from this.

Do you plan to use Xeomin in your practice, and what do you expect from its use?

Definitely, I will use Xeomin in my medical practice. I have been waiting for it for a long time, and I had a pretty close relationship with this drug. I have already tried it in my practice, and, of course, I will use it. And I expect that my clients will be able to appreciate this drug, and the results from its administration.

What, in your opinion, fundamentally distinguishes Xeomin from analogues?

Xeomin is characterized by predictable and long lasting results. The evidence base for this drug is also large.

Xeomin has the following feature: we can use high total doses in a very flexible regimen.

This is an individual therapy for each patient, because only a doctor can know which protocol to choose in each individual case. The possibilities with Xeomin are simply amazing.

Valentina Grigorievna, you have a very rich professional experience. What do you think is the future of Xeomin on the Ukrainian market?

The future of Xeomin is great because it is a global competitor with all the advantages we just talked about. Based on these advantages, we can say that Xeomin will definitely take a leading position in the aesthetic medicine market in Ukraine. I just believe in it!